
|Videos|June 20, 2022
Adriana Rossi, MD and Luciano J. Costa, MD, PhD on Earlier CAR T in Multiple Myeloma
Author(s)Adriana Rossi, MD, Luciano J. Costa, MD, PhD
Oncologist discuss the possibility of earlier-line CAR T-cell therapies in MM.
Advertisement
This content originally appeared on our sister site,
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Slams REGENXBIO's MPS II Gene Therapy RGX-121 With CRL
2
Around the Helix: Cell and Gene Therapy Company Updates – February 11, 2026
3
ImmunoLogic, Episode 8: "Surgery Meets Immunotherapy: A One-Two Punch for Breast Cancer" With Julia C. Tchou, MD, PhD, FACS
4
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
5














